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Abstract
Background: Colorectal cancer (CRC) is the 2nd largest cause of cancer related mortality in the UK with 40 000
new patients being diagnosed each year. Complications of CRC surgery can occur in the perioperative period that
leads to the requirement of organ support. The aim of this study was to identify pre-operative risk factors that
increased the likelihood of this occurring.
Methods: This is a retrospective observational study of all 6441 patients who underwent colorectal cancer surgery
within the West of Scotland Region between 2005 and 2011. Logistic regression was employed to determine
factors associated with receiving postoperative organ support.
Results: A total of 610 (9 %) patients received organ support. Multivariate analysis identified age ≥65, male gender,
emergency surgery, social deprivation, heart failure and type II diabetes as being independently associated with
organ support postoperatively. After adjusting for demographic and clinical factors, patients with metastatic disease
appeared less likely to receive organ support (p = 0.012).
Conclusions: Nearly one in ten patients undergoing CRC surgery receive organ support in the post operative
period. We identified several risk factors which increase the likelihood of receiving organ support post operatively.
This is relevant when consenting patients about the risks of CRC surgery.
Keywords: Colorectal cancer, Surgery, Organ support, ICU
Abbreviations: CRC, Colorectal cancer; ICU, Intensive care unit; ASA, American Society of Anaesthesiologists;
ICD, International classification of disease; ISD, Information services division; SMR, Standardised mortality ratio;
SICSAG, Scottish Intensive Care Society Audit Group; RRT, Renal replacement therapy; SIMD, Scottish index of
multiple deprivation; MI, Myocardial infarction; CHD, Coronary heart disease; CCF, Congestive cardiac failure
congestive cardiac failure; COPD, Chronic obstructive pulmonary disease; TIIDM, Type II diabetes mellitus;
OR, Odds ratio
Background
In the UK 40,000 people are diagnosed with colorectal
cancer (CRC) annually and it is the second most common
cause of cancer related death [1]. Mortality attributable to
CRC has decreased by approximately 40 % since the
1970s with the introduction of bowel screening, better
surgical techniques and adjuvant chemotherapy [1].
CRC surgery is associated with many early post-
operative complications including wound infections,
persistent ileus, bleeding, anastomotic leak, pneumonia,
urinary tract infections, thromboembolism and cardiac
complications [2]. These complications along with pre-
existing co-morbidities are the commonest reasons for
requirement of post-operative organ support. One
small, single centre study, has reported that CRC made
up 3 % of admissions to intensive care (ICU). In that
study, metabolic, haemodynamic and cardiovascular
complications were the leading causes of admission [3].
Acute complications following colorectal cancer sur-
gery are associated with a detrimental effect on short
and long term survival. The most notable of these
complications is an anastomotic leak, which occurs in
3–14 % [4–8] of patients. It carries a short term mortality
of 7–18 % [8–10] and is associated with poor long term
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cancer outcomes in terms of both survival [5, 11, 12] and
recurrence [13, 14]. This complication generally occurs
6 days post-operatively and has a wide spectrum of pre-
sentations. Whilst many small leaks remain subclinical,
for some it presents with life-threatening intra-abdominal
sepsis and multi-organ failure requiring ICU admission
for organ support.
Many studies have tried to determine the risk factors as-
sociated with postoperative morbidity and mortality in this
population. They include male sex [15–20], increasing age
[16, 21–25], American Society of Anesthesiologists (ASA)
Physical Status score [22, 24, 25], co-morbidities [16, 20,
21, 26–29], advanced tumour stage [15, 22, 24, 25, 29],
neoadjuvant chemotherapy [15], emergency surgery
[21, 22, 24, 25], proximity of surgery to the anal verge
[15, 18, 19] and social deprivation [30]. However, there
was a wide variety in the ways in which morbidity and
mortality were described through the literature and
many of the studies were from single centres with small
sample sizes.
As our population becomes increasingly elderly, more
patients with significant co-morbidities will be considered
for surgical intervention. No study, to our knowledge, has
reported the proportion of patients requiring organ sup-
port or the type of organ support required, following CRC
surgery. Identifying patients who were likely to require
organ support would allow us to optimise the patient
journey and appropriately consent high-risk patients.
Methods
Study design
This is a multi-centre, retrospective, observational study
assessing which pre-operative factors predict receipt of
organ support following CRC surgery. We identified
patients resident in the West of Scotland region that had
a diagnosis of a CRC on the Scottish Cancer Registry
between 2005 and 2011 and determined whether they
had undergone CRC surgery. We then established which
of these patients were admitted to ICU for organ support
in the post-operative period. (See Fig. 1)
Data
The Scottish Cancer Registry collects information on all
new cases of cancer including primary malignant neo-
plasms, carcinoma in-situ, neoplasms of uncertain behav-
iour and benign brain and spinal cord tumours. Cancer
diagnoses are coded to the International Classification of
Diseases 10th revision (ICD-10). The registry is linked by
the Information Services Division (ISD) of NHS Scotland
to Scottish Morbidity records (SMR01) which detail all
hospital discharges, National Records of Scotland death
records and to The Scottish Intensive Care Society Audit
Group (SICSAG) WardWatcher (Critical Care Audit Ltd,
Otley, Yorkshire) ICU audit database.
The SICSAG WardWatcher audit system is a national
database used in Scotland to collect data on patient
demography, admitting specialty and diagnosis, patient’s
Fig. 1 Consort diagram of cohort
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prior location, known co-morbidities and type of organ
support for all ICU admissions. Organ support was de-
fined as invasive mechanical ventilation via endotracheal
tube or tracheostomy, use of inotropic or vasopressor
medication or renal replacement therapy (RRT) of any
modality. We used the Scottish Index of Multiple
Deprivation (SIMD) to describe deprivation by geo-
graphical location ranking areas from most deprived (1st
quintile) to least deprived (5th quintile). Previous research
using this index has shown that a higher level of socioeco-
nomic deprivation is associated with poorer survival fol-
lowing colorectal cancer surgery [31]. This is thought to
be due to higher early postoperative mortality in patients
from more deprived areas [32]. Co-morbidities were iden-
tified using the SMR 01 data where hospitalisations in the
previous 5 years were identified and the diagnosis field
was searched for any of the following: myocardial infarc-
tion (MI)/ coronary heart disease (CHD), congestive car-
diac failure (CCF), chronic obstructive pulmonary disease
(COPD)/ asthma, or type II diabetes mellitus (TIIDM).
Population
The West of Scotland has a population of 2.4 million. It is
predominantly urban with the majority of the population
living within the city of Glasgow or in large towns. There
were 15 general ICUs in the area during the study period.
Some functioned as combined ICU/ High Dependency
Units (HDU) for some or all of the time period.
Inclusion criteria
We defined patients as having CRC if they were resident
in the West of Scotland and had a diagnosis of CRC
(ICD-10 C18.0-18.9, C19 and C20) in the Scottish
Cancer Registry between 1st January 2005 and 31st
December 2011. SMR-01 data relating to any hospitalisa-
tion within 3 months of cancer incidence identified
patients who had received CRC surgery (OPCS codes
H04-H11, H13, H15, H29, H33, X14).
Patients admitted to ICU during the same inpatient stay
associated with their colorectal surgery were identified.
The Ward Watcher database records of these patients
were then used to ascertain whether one of mechanical
ventilation, vasopressor therapy or renal replacement
therapy was required during their stay in ICU. If the
patient had more than one ICU admission at any point
in their cancer journey we only used data from the
index admission.
Following any surgical procedure it is routine practice
to transfer the patient to a recovery area until the patient
has recovered from anaesthesia. Once stable the patient is
then transferred to the surgical ward or high dependency
unit. It is not routine practice to admit post-operative pa-
tients to ICU unless there is ongoing organ dysfunction
requiring the provision of organ support.
Emergency and elective surgery patients
The type of the hospital admission was determined using
SMR-01 codes for either elective or emergency hospital
admissions. If an admission was associated with only 1
surgical procedure during the hospital stay then the
patient’s surgery was determined to be the same as the
type of hospital admission (either elective or emergency).
If, however, a patient was admitted to hospital electively
but underwent more than 1 surgical procedure then the
patient was classified as an “Emergency Surgery” patient.
These patients were deemed to have required emergency
surgery following their initial elective surgery e.g., for
the repair of an anastomotic leak.
Statistical analysis
Continuous variables were summarised as medians with
interquartile range. X2 test of association was used to
assess differences in baseline characteristics between
those who received organ support and those who did
not. Multiple logistic regression analysis was used to test
associations between receipt of organ support and
demographic and clinical variables and receipt of organ
support. Only variables that would have been known
prior to surgery were used for logistic regression ana-
lysis. All variables were included in both univariate and
multivariate analysis. Results were considered to be sta-
tistically significant if the p-value was <0.05. Statistical
analyses were performed using Stata (Stata Statistical
Software: Release 12. College Station, TX).
Results
Patient demographics
A total of 6,441 (median age 70 (IQR 62–77), 53 % male)
patients underwent surgery for CRC during the study
period. Post-operative organ support was provided to 610
patients (9 %) with a median age 71 (IQR 64–68), of
whom 61 % male. Patient demographics and the propor-
tions who received organ support are reported in Table 1.
The proportion of patients who received post-operative
organ support was higher in men compared to women
(11 % vs. 8 %, p < 0.001), patients aged ≥65 years
compared to under 65 (10 % vs. 8 % p < 0.001), and in
emergency as opposed to elective surgical patients (18 %
vs. 6 % p < 0.001). Post-operative organ support was
provided to 22 % of patients with heart failure and 15 % of
patients with type II diabetes compared to 9 % in those
who had no major co-morbidity.
Hospital mortality for all patients undergoing CRC
surgery was 6 %. This was significantly higher in patients
who received organ support compared with those who
did not (28 % vs. 3 % p < 0.001) (Table 2). Patients who
received organ support (9 % of all the CRC surgery pa-
tients) accounted for 48 % of all in-hospital deaths
among CRC surgery patients. Figure 2 shows the Kaplan
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Meier survival curves for patients who received and did
not receive organ support. Six month mortality for all
patients was 11 % and was considerably higher in those
that received post operative organ support (35 % vs. 8 %
p < 0.001).
Factors associated with post operative organ support
Multivariate adjusted odds ratios (OR) for pre-operative
factors associated with post operative organ support are
shown in Table 3. Age ≥65 (OR 1.37 95 % CI 1.12–1.67),
Table 1 Characteristics of patients undergoing colorectal cancer surgery categorised on their requirement for postoperative organ
support
Baseline Characteristic All patients
(n = 6441)
Number receiving organ
Support (n = 610)
Percent receiving organ
support (95 % CI)
p-value*
Sex Men 3444 (53) 371 (61) 10.8 (9.8–11.9) <0.001
Women 2997 (47) 239 (39) 8.0 (7.0–9.0)
Age (yrs) Median 70 (62–77) 71 (64–78)
Age group (yrs) ≥65 4384 (68) 455 (75) 10.4 (9.5–11.3) <0.001
<65 2057 (32) 155 (25) 7.5 (6.4–8.7)
SIMD quintile 1 -most deprived 1718 (27) 176 (29) 10.2 (8.9–11.8) 0.023
2 1519 (24) 161 (26) 10.5 (7.2–10.0)
3 1240 (19) 119 (20) 9.6 (8.0–11.3)
4 973 (15) 85 (14) 8.7 (7.0–10.7)
5 - least deprived 991 (15) 69 (11) 7.0 (5.5–8.7)
Surgery type Elective 4692 (73) 298 (49) 6.4 (5.7–7.1) <0.001
Emergency 1749 (27) 312 (51) 17.8 (16.1–19.7)
Number of hospital admissions in previous 5 years 0 2437 (38) 206 (34) 8.4 (7.4–9.6) 0.008
1 1631 (25) 139 (23) 8.5 (7.2–10.0)
2 905 (14) 95 (16) 10.5 (8.6–12.7)
3 564 (9) 59 (10) 10.5 (8.1–13.3)
4 325 (5) 36 (6) 11.1 (7.9–15.0)
≥5 579 (9) 75 (12) 13.0 (10.3–16.0)
Dukes Stage A 974 (15) 76 (12) 7.8 (6.2–9.7) 0.062
B 2284 (35) 209 (34) 9.2 (8.0–10.4)
C 2126 (33) 228 (37) 10.7 (9.4–12.1)
D 651 (10) 54 (9) 8.3 (6.3–10.7)
Not recorded 406 (6) 43 (7) 10.6 (7.8–14.0)
Cancer Site Colon 4802 (75) 471 (77) 9.8 (9.0–10.7) 0.113
Rectum 1639 (25) 139 (23) 8.5 (7.2–10.0)
Co-morbidities MI or IHD 510 (8) 69 (11) 13.5 (10.7–16.8) 0.001
CCF 150 (2) 33 (5) 22.0 (15.7–29.5) <0.001
COPD or Asthma 293 (5) 37 (6) 12.6 (9.0–17.0) 0.059
TIIDM 281 (4) 43 (7) 15.3 (11.3–20.1) 0.001
Values are numbers (%) or median (inter-quartile range)
* test for differences between categories within each variable, with the exception of comorbidities which is compared to patients without any of the
stated comorbidities
SIMD Scottish Index of Multiple Deprivation, IHD ischaemic heart disease, MI myocardial infarction, CCF congestive cardiac failure, COPD chronic obstructive
pulmonary disease, TIIDM type II diabetes mellitus
Table 2 Hospital and 6 month mortality for patients who did
and did not receive organ support
Hospital Mortality
(95 % CI)
6 month mortality
(95 % CI)
Received organ support 28 % (24.8–32.1) 35 % (31.0–38.9)
Did not receive organ
support
3 % (2.7–3.7) 8 % (7.5–8.9)
p-value <0.001 <0.001
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male sex (OR 1.46 95 % 1.22–1.74), and undergoing
emergency surgery (OR 3.45 95 % CI 2.88–4.14) were
independently associated with receiving organ support
following CRC surgery. Additionally patients with CCF
(OR 2.07 95 % CI 1.32–3.27) or TIIDM (OR 1.49 95 %
CI 1.04–2.14) had an increased likelihood of postopera-
tive organ support on multivariate analysis.
Increasing SIMD quintile (less social deprivation) (OR
0.93 95 % CI 0.88–0.99) and having metastatic disease
(OR 0.61 95 % CI 0.42–0.90) were independently associ-
ated with a decreased likelihood of admission to ICU for
post-operative organ support.
We assessed the effect the total number of risk factors
had on the risk of post-operative organ support. With an
increasing number of risk factors, there was an increase
in the proportion of patients who received post-
operative organ support. Only 3 % of those patients with
no identified risk factors required post-operative organ
support compared with 31 % in those with 4 or more
risk factors. In patients with no known risk factors, 3 %
of elective patients received post-operative organ sup-
port compared with 13 % of those undergoing emer-
gency surgery (Fig. 3). For both elective and emergency
surgery patients, an increasing number of risk factors re-
sulted in an increased proportion of patients in receipt
of organ support.
Organ support received
A total of 610 patients received at least one form of organ
support following CRC surgery with mechanical ventila-
tion being the commonest. It was required in 8 % of all
CRC surgery patients post-operatively; thus 84 % of CRC
patients who received any form of organ support, required
ventilation. Seven percent of all patients (72 % of organ
support patients) received vasoactive drugs and 1 % (11 %)
renal replacement therapy.
Dukes staging
A greater proportion of emergency patients presented
with Dukes D disease compared with elective surgery
(18 % vs. 7 %, p-value <0.001). On multivariate analysis
Dukes stage D patients were less likely to receive organ
support than patients with stage A disease OR 0.61
(95 % CI 0.42–0.9, p 0.012). However, once admitted to
ICU for organ support Dukes staging did not appear to
affect the level of organ support. The proportion of
Dukes A and Dukes D patients receiving more than one
form of organ support were similar at 57 and 58 % re-
spectively (p = 0.596). Although there was no difference
in the proportions of patients receiving mechanical ven-
tilation (Dukes A 76 % versus Dukes D 89 %, p = 0.069)
or renal replacement therapy (Dukes A 16 % versus
Dukes D 9 %, p = 0.277), only 63 % of patients with
Dukes Stage D received vasoactive drugs compared with
80 % of those with Dukes stage A (p = 0.028).
Elective versus emergency surgery
Of patients receiving organ support, 55 % of elective
surgery patients received more than one form of organ
support compared with 59 % in the emergency surgery
group (p = 0.289) yet only 7 % of emergency patients
received 3 forms of organ support vs. 13 % of elective
surgery patients (p = 0.014). Seventy-nine percent of
elective patients received mechanical ventilation com-
pared with 89 % of emergency surgery patients (p = 0.001).
Elective surgery patients were more likely to receive RRT
compared with emergency surgery patients at 14 and 8 %
respectively (p = 0.023), however, there was no difference
in the receipt of vasoactive drugs between emergency ver-
sus elective patients (76 % vs. 70 % respectively, p = 0.119).
Discussion
Post-operative organ dysfunction significantly alters the
surgical course, recovery and mortality from CRC surgery.
Fig. 2 Kaplan Meier survival plot indicating patients who received and did not receive organ support
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This study has found that age ≥65, male sex, emergency
surgery, increasing social deprivation, congestive cardiac
failure and Type II Diabetes Mellitus increase the likeli-
hood of organ support being provided in the perioperative
period. We found that nearly 10 % of CRC surgical pa-
tients received post-operative organ support with an asso-
ciated increase in hospital mortality of almost ten-fold
(28 % versus 3 % respectively).
In the UK, elective CRC patients have standardised
care pathways and optimisation prior to surgery in a way
that cannot exist for the emergency patient. They have
been assessed and counselled with regards to the level of
risk and ‘fitness for theatre’. The finding that emergency
patients are more likely to require organ support than
elective patients post-operatively (18 % versus 6 %) re-
flects this disparity. Emergency patients are more likely
to present with an acute abdominal insult, which may be
preceded by a period of illness. The delayed presentation
is apparent in our study by the finding that a greater
proportion of emergency patients had Dukes D disease
compared with the elective surgical population (18 % vs
7 %, p-value <0.001). Advanced cancer presentation often
Table 3 Predictive factors for receiving organ support following CRC surgery
Multivariate Analysis
Baseline Characteristics Odds Ratio
(95 % CI)
p-value
Sex Women 1
Men 1.46 (1.22–1.74) <0.001
Age group at incidence <65 1
≥65 1.37 (1.12–1.67) 0.002
SIMD quintile 1 - most deprived 1
2 1.08 (0.85–1.36) 0.53
3 0.99 (0.77–1.27) 0.92
4 0.86 (0.65–1.14) 0.29
5 - least deprived 0.74 (0.55–1.00) 0.05
0.026*
Number of hospital admissions in previous five years 0 1
1 0.98 (0.78–1.24) 0.87
2 1.18 (0.90–1.55) 0.22
3 1.10 (0.80–1.52) 0.56
4 1.18 (0.79–1.77) 0.41
≥5 1.26 (0.91–1.73) 0.16
Duke’s Stage A 1
B 0.90 (0.68–1.20) 0.47
C 1.03 (0.78–1.37) 0.83
D 0.61 (0.42–0.90) 0.012
Not recorded 0.85 (0.56–1.28) 0.43
Cancer Site Colon 1
Rectum 1.08 (0.88–1.34) 0.46
Nature of Surgery Elective 1
Emergency 3.45 (2.88–4.14) <0.001
Major Comorbidities No CHD/MI, CCF, COPD/asthma, TIIDM 1
CHD/MI 1.00 (0.72–1.38) 1
CCF 2.07 (1.32–3.27) <0.001
COPD/asthma 1.04 (0.71–1.53) 0.83
TIIDM 1.49 (1.04–2.14) 0.032
* test for trend
SIMD Scottish Index of Multiple Deprivation, IHD ischaemic heart disease, MI myocardial infarction, CCF congestive cardiac failure, COPD chronic obstructive
pulmonary disease, TIIDM type II diabetes mellitus
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results in patients with poorer physiological reserve and
prognosis [25] and may explain why elective patients were
more likely to receive 3 forms of organ support compared
with emergency surgery (13 % vs 7 %, p = 0.014). Thus it is
not surprising that prior studies have demonstrated that
emergency surgery is a poor prognostic factor both in
terms of short and long term survival [33, 34].
It is difficult to attribute pathophysiological mecha-
nisms to each individual risk factor. However male gen-
der being found to increase likelihood of organ support
may be explained, at least in part, by surgery in the
anatomically narrower male pelvis being more technic-
ally challenging thus leading to a potential increase in
the likelihood of anastomotic leak.
Metastatic disease was associated with a decreased
likelihood of receiving organ support following CRC
surgery. It seems doubtful that those patients with ad-
vanced disease are less likely to develop organ failure
and instead we would postulate that these patients
have been considered inappropriate candidates for
organ support and ICU intervention. In general there
is a reluctance to expose these patients to the aggres-
sive and unpleasant treatment of ICU and instead focus
care towards palliation [35].
Further research is required to address factors that in-
fluence both the short and longer-termsurvival in CRC
patients in ICU in order to provide a comprehensive
description of these patients. The findings that certain
co-morbidities such as CCF and TIIDM increase the
likelihood of receiving organ support following CRC sur-
gery allow us to identify at risk individuals. There may
also be a role for optimising the management of these
conditions prior to and following surgery to improve
outcomes in this group of patients. In addition it might
allow the opportunity for discussions regarding advanced
directives to take place.
Strengths and limitations
The assessment of the effect of nature of surgery is a po-
tential drawback of this study. Due to the nature of the
database a number of patients who received an “emer-
gency surgery” may have initially been admitted for an
elective surgery in the same hospital admission. Neverthe-
less, this group of patients is still representative in showing
the effect that unplanned surgery has on perioperative
outcomes even if as a patient group they differ slightly
from the literature’s traditional description of emergency
CRC surgery patients.
Although analysed retrospectively, this study has been
performed using prospectively collected data that is
entered into national databases. Within the West of
Scotland, every ICU patient is admitted onto the
Wardwatcher database and every new cancer diagnosis
is entered into the Cancer Registry thus ensuring we
capture the appropriate population. The unique identi-
fier (CHI) used in Scotland also makes data linkage
more robust. The main limitation of using databases is
the level of detail contained within them and the accur-
acy of the data entry. However, we believe that this
study of over 6000 cancer patients highlights the sig-
nificant morbidity and mortality facing nearly 10 % of
CRC patients in the perioperative period. This may
allow for better risk assessment and optimisation in the
perioperative period.
Conclusions
Nearly one in ten patients undergoing CRC surgery re-
ceive organ support in the post operative period. This
was associated with a significant increase in mortality
with organ support patients having a hospital mortality
close to ten times that of those without organ support.
We identified several risk factors which increase the
likelihood of receiving organ support post operatively
Fig. 3 Percent of patients receiving organ support according to number of risk factors
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including advanced age, emergency surgery, male sex
and certain co-morbidities. These appear to have an
additive effect with an increased likelihood of organ sup-
port being received with each additional risk factor.
Emergency surgery had the greatest impact in terms of
impact on requirement for post-operative organ support.
Post operative organ support is not routinely discussed
with patients undergoing CRC surgery, however, given
the frequency that this occurs and the significant impact
upon outcomes we suggest that this should considered
in patients with features associated with increased risk.
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